|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Stat3 activation is required for the growth of U87 cell-derived tumours in mice显示文摘 | Atreyi Dasgupta Baisakhi Raychaudhuri Talat Haqqi Richard Prayson Erwin G. Van Meir Michael Vogelbaum Saikh Jaharul Haque | 2008 | European Journal of Cancer2008，，4： | 1 |
| 2 | Studying users,computer security behavior:A Health Belief Perspective显示文摘 | Boon-Yuen N Atreyi K | 2009 | Decision Support Sys-terns2009，46，4： | 1 |
| 3 | Automatic partitioning of full-motion video显示文摘 | HongJiang Zhang Atreyi Kankanhalli Stephen W. Smoliar | 1993 | Multimedia Systems1993，，1： | 1 |
| 4 | Perchlorate degradation using an indigenous microbial consortium predominantly burkholderia sp 显示文摘 | Atreyi G Kannan P Ghosh P K | 2011 | Journal of Hazardous Materials2011，23，5： | 1 |
| 5 | Automatic partitioning of full-motion video显示文摘 | HongJiang Zhang Atreyi Kankanhalli Stephen W. Smoliar | 1993 | Multimedia Systems1993，，1： | 1 |
| 6 | Automatic partitioning of full-motion video显示文摘 | HongJiang Zhang Atreyi Kankanhalli Stephen W. Smoliar | 1993 | Multimedia Systems1993，，1： | 1 |
| 7 | Interaction of methy- lene blue with transfer RNA a spectroscopicstudy显示文摘 | Antony T Atreyi M Rao MV | 1995 | Chem Biol Interact1995，97，3： | 1 |
| 8 | Elimination of lymphatic filariasis:Where do we stand so far?显示文摘Lymphatic filariasis(LF),an asymptomatic,acute,and chronic condition in human beings,is the second most common vector-borne disease after malaria.According to the World Health Organization,there are 120 million LF cases detected in 81 tropical and subtropical countries,and one billion people are at risk.Therefore,the Global Program to Eliminate Lymphatic Filariasis was launched in 2000,with the primary objective of stopping LF transmission among all at-risk groups using mass drug administration(MDA),managing morbidities,and preventing LF-related impairments using a minimum treatment package.Additionally,other programs such as epidemiological assessment including National Filaria Control Program and World Health Organization recommended routine and pre-MDA microfilaremia surveys also implemented to stop the LF transmission.The routine filaria surveys were also carried out in around 2000-4000 individuals/month throughout the year whereas pre-MDA surveys were also conducted every year in approximately 4000 individuals in four fixed and four random sites.Furthermore,the Transmission Assessment Survey was also conducted to check the risk of LF among primary school children.Moreover,potential diagnostic methods,systematic surveillance regimes,the Direct Network Report system,and regular trainings and awareness may be also effective in preventing the recurrence of LF.Hence,this review emphasizes the potential advocacy tools and various strategies as well as procedures for monitoring,which could be impactful in eliminating LF. | Aashna Sinha Sudhashekhar Kumar Deen Dayal Vaishali Yadav Atreyi Pramanik Kundan Kumar Chaubey Sanjay Kumar | 2023 | Asian Pacific Journal of Tropical Medicine2023，16，9： | 1 |
| 9 | Anintegrative study of information systems security effec-tiveness 显示文摘 | ATREYI K TEO H H BERNARD C Y | 2003 | International Journal of InformationManagement2003，23，2： | 1 |
| 10 | Contributing Knowledge to Electronic Knowledge Repositories: An Empirical Investigation显示文摘 | Kankanhalli Atreyi Tan Bernard C Y Kwok - kee Wei | 2005 | MIS Quarterly2005，29，1： | 1 |
| 11 | Contributing Knowledge to Electronic Knowledge Repositories : An Empirical Investigation 显示文摘 | Kankanhalli Atreyi Bernard C Y Tan Wei Kwok- Kee | 2005 | MIS Quarterly2005，29，1： | 1 |
| 12 | What Motivates People to Purchase Digital Items on Virtual Community Websites? The Desire for Online Self-Presentation显示文摘 | Hee-Woong Kim Hock Chuan Chan Atreyi Kankanhalli | 2012 | Information Systems Research2012，，4： | 1 |
| 13 | Automatic partitioning of full-motion video显示文摘 | Hongjiang Zhang Atreyi Kankanhalli Stephen W Smoliar | 1993 | Multimedia Systems1993，1，1： | 1 |
| 14 | Contributing Knowledge to Electronic Knowledge Repesitories:an Empirical Investigation显示文摘 | Atreyi Kankanhalli Bernard C Y Tan Kwok-Kee Wei | 2005 | MIS Quarterly2005，29，1： | 1 |
| 15 | Perceptions of Information Security in the Workplace: Linking Information Security Climate to Com- pliance Behavior 显示文摘 | Chan M Irene W Atreyi K | 2005 | Journal of Information Privacy & Security2005，3，1： | 1 |
| 16 | Targeting the complement system in pancreatic cancer drug resistance:a novel therapeutic approach显示文摘Pancreatic cancer is ranked as the fourth leading cause of cancer-related mortality and is predicted to become the second leading cause of cancer-related death by 2030.The cause of this high mortality rate is due to pancreatic ductal adenocarcinoma’s rapid progression and metastasis,and development of drug resistance.Today,cancer immunotherapy is becoming a strong candidate to not only treat various cancers but also to combat against chemoresistance.Studies have suggested that complement system pathways play an important role in cancer progression and chemoresistance,especially in pancreatic cancer.A recent report also suggested that several signaling pathways play an important role in causing chemoresistance in pancreatic cancer,major ones including nuclear factor kappa B,signal transducer and activator of transcription 3,c-mesenchymal-epithelial transition factor,and phosphoinositide-3-kinase/protein kinase B.In addition,it has also been proven that the complement system has a very active role in establishing the tumor microenvironment,which would aid in promoting tumorigenesis,progression,metastasis,and recurrence.Interestingly,it has been shown that the downstream products of the complement system directly upregulate inflammatory mediators,which in turn activate these chemo-resistant pathways.Therefore,targeting complement pathways could be an innovative approach to combat against pancreatic cancer drugs resistance.In this review,we have discussed the role of complement system pathways in pancreatic cancer drug resistance and a special focus on the complement as a therapeutic target in pancreatic cancer. | Naushair Hussain Deea Das Atreyi Pramanik Manoj K Pandey Vivek Joshi Kartick C.Pramanik | 2022 | Cancer Drug Resistance2022，5，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员